Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

New life for an old therapy: ELTD1 as a downstream target of angiogenesis

Neuro-Oncology(2021)10.1093/neuonc/noab286Source: DataRank Database

New life for an old therapy: ELTD1 as a downstream target of angiogenesis is a research paper published in Neuro-Oncology (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: bronzeTopics (23)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Shi-Yuan Cheng ORCID,Deanna Tiek ORCID

Live enrichment

PubMed:35015881 OpenAlex:https://openalex.org/W4205153528

National Institutes of Health

Grant: NS115403

National Institutes of Health

Grant: 5R01NS115403-04

Role of Protein Methylation in Cell Mitosis and Glioblastoma

NINDS NIH HHS

Grant: R01 NS115403

NINDS NIH HHS

Grant: R01 NS125318

NCI NIH HHS

Grant: R21 CA209345

FWCI

0.00

Citation Percentile

0.2%

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/neuro-oncology/article-pdf/24/3/412/42854537/noab286.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/24/3/412/42854537/noab286.pdf

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noab286/42182569/noab286.pdf

journalhttps://doi.org/10.1093/neuonc/noab286

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35015881

Fields of Study

Glioma Diagnosis and TreatmentCancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerHumansNeovascularization, PathologicReceptors, G-Protein-Coupled

MeSH Terms

HumansNeovascularization, PathologicReceptors, G-Protein-Coupled

Keywords

BevacizumabMedicineTemozolomideAngiogenesisVascular endothelial growth factorRadiation therapyOncologyInternal medicineCancer researchChemotherapyVEGF receptorsNeovascularization, PathologicHumansReceptors, G-Protein-Coupled

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being